82001-62-5

Basic information

• Product Name: Ethanethioic acid, S-[3-phenyl-2-[[(phenylmethoxy)carbonyl]amino]propyl] ester, (S)-
• CAS NO: 82001-62-5
• Molecular Formula: C19H21NO3S
• Molecular Weight: 343.447
• Mol File: 82001-62-5.mol
• Article Data: 11

Chemical Properties

• CAS DataBase Reference: Ethanethioic acid, S-[3-phenyl-2-[[(phenylmethoxy)carbonyl]amino]propyl] ester, (S)-(CAS DataBase Reference)
• NIST Chemistry Reference: Ethanethioic acid, S-[3-phenyl-2-[[(phenylmethoxy)carbonyl]amino]propyl] ester, (S)-(82001-62-5)
• EPA Substance Registry System: Ethanethioic acid, S-[3-phenyl-2-[[(phenylmethoxy)carbonyl]amino]propyl] ester, (S)-(82001-62-5)

Safety Data

• Hazardous Substances Data: 82001-62-5(Hazardous Substances Data)

Upstream product

• 507-09-5 tiolacetic acid 
• 41518-17-6 Z-Phe-O-COO-isoBu 
• 1161-13-3 N-Cbz-L-Phe 
• 135731-20-3 (S)-2-{[(benzyloxy)carbonyl]amino}-3-phenylpropyl methanesulfonate 
• 10387-40-3 potassium thioacetate 
• 6372-14-1 N-((benzyloxy)carbonyl)-L-phenylalaninol 
• 501-53-1 benzyl chloroformate 
• 3182-95-4 L-Phenylalaninol 

Downstream Products

• 126301-32-4 (S)-2-amino-3-phenylpropane-1-sulfonic acid 
• 856570-20-2 (S)-2-Benzyloxycarbonylamino-3-phenyl-propane-1-sulfonic acid 
• 1169199-24-9 Cbz-Phe-ψ[CH2SO2]-F 
• 1169199-29-4 Cbz-Phe-ψ[CH2SO2NH]-β-Ala-ψ[CH2SO2]-F 
• 1300689-96-6 L-Phe-[CH₂SO₂]-FHCl 
• 1206530-78-0 (S)-(2-benzyloxycarbonylamino-3-phenyl)propanesulfonamide 

Relevant articles and documents

Novel sulfonamide-based carbamates as selective inhibitors of bche

A series of 14 target benzyl [2-(arylsulfamoyl)-1-substituted-ethyl]carbamates was prepared by multi-step synthesis and characterized. All the final compounds were tested for their abil-ity to inhibit acetylcholinesterase (AChE) and butyrylcholinesterase

PROTEASOME INHIBITOR COMPRISING A SIGNAL-EMITTING MOIETY

The present invention relates to compounds such as peptides which act as proteasome inhibitors. The compounds are covalently linked with a signal emitting compound or a precursor thereof, via an ester such as a sulfonic ester group for imaging of the inhibition of the proteasome. The compound is for use in the quantification of proteasomal inhibition, diagnosis and/or prevention and/or treatment of autoimmune diseases, cancer, neurodegenerative diseases, viral infections and/or diseases associated with inflammation. The invention further relates to methods to produce the compounds.

An efficient and facile synthesis of N-Cbz-β-aminoalkanesulfonamides

An efficient method for the synthesis of N-Cbz-β- aminoalkanesulfonamides was described. N-Cbz-β-aminoalkanesulfona-mides were readily prepared in good yields from a variety of amino alcohols, including optically active ones, via N-Cbz protection with ben